Eli Lilly
LLY on XNYS, Eli Lilly & Co.
Measures activity, not value. Not investment advice.
New positions, last 12 months
947
+47% vs the 12 months before
Positions closed, last 12 months
521
-17% vs the 12 months before
Net, last 12 months
+426
new positions minus positions closed
Sharp changes
1
many funds opening a new position
What usually follows Change in institutional holders was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
Largest holders over the last 8 quarters
Shares reported on Form 13F at each quarter end; the 10 largest holders of Q3 2026. "–": no full report for that quarter (not filed yet, or positions kept confidential)| Institution | Trend | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Lilly Endowment Inc | 96.9M | 96.0M | 96.0M | 95.5M | 92.2M | 91.9M | 90.4M | 90.1M | |
| BlackRock, Inc. | 65.2M | 65.7M | 66.0M | 65.8M | 66.8M | 66.4M | 67.5M | 67.9M | |
| Vanguard Capital Management LLC | – | – | – | – | – | 53.4M | 53.5M | 53.9M | |
| PNC Financial Services Group, Inc. | 51.3M | 101.3M | 51.3M | 51.4M | 51.3M | 51.3M | 51.3M | 51.3M | |
| State Street Corp | 34.3M | 34.4M | 34.5M | 34.7M | 35.4M | 35.6M | 36.2M | 36.8M | |
| FMR LLC (Fidelity) | 32.0M | 29.9M | 25.6M | 24.2M | 25.7M | 26.3M | 28.5M | 30.0M | |
| Vanguard Portfolio Management LLC | – | – | – | – | – | 21.0M | 20.9M | 21.0M | |
| Geode Capital Management, LLC | 17.4M | 18.5M | 18.1M | 19.8M | 19.8M | 20.2M | 20.3M | 20.6M | |
| Capital Research Global Investors | 10.8M | 15.7M | 20.8M | 25.1M | 24.6M | 24.6M | 20.9M | 17.0M | |
| Morgan Stanley | 14.4M | 14.9M | 14.9M | 15.2M | 15.6M | 15.4M | 16.2M | 16.4M |
Form 13F holdings by quarter end.
See the numbers
| Quarter of Jul 2026: new positions 157, positions closed 137 |
| Quarter of Apr 2026: new positions 327, positions closed 92 |
| Quarter of Jan 2026: new positions 146, positions closed 202 |
| Quarter of Oct 2025: new positions 317, positions closed 90 |
| Quarter of Jul 2025: new positions 158, positions closed 146 |
| Quarter of Apr 2025: new positions 157, positions closed 154 |
| Quarter of Jan 2025: new positions 187, positions closed 146 |
| Quarter of Oct 2024: new positions 144, positions closed 182 |
| Quarter of Jul 2024: new positions 169, positions closed 101 |
| Quarter of Apr 2024: new positions 195, positions closed 110 |
| Quarter of Jan 2024: new positions 251, positions closed 97 |
| Quarter of Oct 2023: new positions 169, positions closed 83 |
| Quarter of Jul 2023: new positions 218, positions closed 69 |
| Quarter of Apr 2023: new positions 221, positions closed 73 |
| Quarter of Jan 2023: new positions 96, positions closed 132 |
| Quarter of Oct 2022: new positions 163, positions closed 79 |
| Quarter of Jul 2022: new positions 117, positions closed 74 |
| Quarter of Apr 2022: new positions 168, positions closed 75 |
| Quarter of Jan 2022: new positions 115, positions closed 89 |
| Quarter of Oct 2021: new positions 167, positions closed 77 |
| Quarter of Jul 2021: new positions 99, positions closed 70 |
| Quarter of Apr 2021: new positions 151, positions closed 89 |
| Quarter of Jan 2021: new positions 128, positions closed 80 |
| Quarter of Oct 2020: new positions 116, positions closed 95 |
| Quarter of Jul 2020: new positions 106, positions closed 107 |
| Quarter of Apr 2020: new positions 146, positions closed 78 |
| Quarter of Jan 2020: new positions 100, positions closed 76 |
| Quarter of Oct 2019: new positions 101, positions closed 62 |
| Quarter of Jul 2019: new positions 72, positions closed 61 |
| Quarter of Apr 2019: new positions 74, positions closed 133 |
| Quarter of Jan 2019: new positions 112, positions closed 82 |
| Quarter of Oct 2018: new positions 97, positions closed 75 |
| Quarter of Jul 2018: new positions 115, positions closed 58 |
| Quarter of Apr 2018: new positions 95, positions closed 63 |
| Quarter of Jan 2018: new positions 66, positions closed 103 |
| Quarter of Oct 2017: new positions 81, positions closed 41 |
| Quarter of Jul 2017: new positions 48, positions closed 70 |
| Quarter of Apr 2017: new positions 56, positions closed 57 |
| Quarter of Jan 2017: new positions 76, positions closed 53 |
| Quarter of Oct 2016: new positions 67, positions closed 81 |
What the numbers say
- New positions: 157 vs positions closed: 137 in the quarter from 1 Jul 2026.
- Net new institutional positions over 12 months: 426, number 2 of 820 Health Care companies with data (median 14).
- 1 sharp change in all loaded history (many funds opening a new position).
- 13F moves in the last four quarters: the largest is added, 7,643 (50%).
- Latest record: GQG Partners LLC opened a $878.0M position (2026Q3 13F), public on 13 Nov 2026.
See the numbers
| Added | 7,643 (50%) |
| Cut | 6,072 (40%) |
| Opened | 947 (6.2%) |
| Closed | 521 (3.4%) |
Every measure from this source
5 years, by the period each figure describes
Sharp changes
1 in all loaded history, strongest first
Eli Lilly saw 319 13F filers open a new position in the quarter ended 31 Dec 2025, 2.2× the same quarter last year.
Same quarter last year: 146; its normal quarter is 170.
See the evidence
- This period
- 319 (the quarter ended 31 Dec 2025)
- Normal quarter (median of 8 earlier)
- 170
- Typical spread (median absolute deviation)
- 14
- How far from its usual level
- +7.2
- Same quarter last year
- 146
- History used
- 4,475 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Check it at the source: SEC Form 13F data sets.
The records
Newest first, by the day each became public